XRTX
XORTX Therapeutics Inc
NASDAQ: XRTX · HEALTHCARE · BIOTECHNOLOGY
$2.86
+4.76% today
Updated 2026-04-30
Market cap
$4.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.80
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
XORTX Therapeutics Inc (XRTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $180089.00 | $282463.00 | $490602.00 | $1.27M | $1.09M | $1.80M | $21.98M | $12.34M | $5.47M | $4.09M |
| Cash & equivalents | $762.00 | $16769.00 | $61939.00 | $260019.00 | $58614.00 | $134313.00 | $18.80M | $10.41M | $3.45M | $2.47M |
| Current assets | $10935.00 | $18335.00 | $63547.00 | $979648.00 | $815248.00 | $1.61M | $20.12M | $10.87M | $4.07M | $2.68M |
| Total liabilities | $60162.00 | $599525.00 | $1.15M | $943702.00 | $1.30M | $811045.00 | $5.28M | $5.37M | $825938.00 | $757990.00 |
| Current liabilities | $60162.00 | $599525.00 | $1.11M | $900447.00 | $1.30M | $811045.00 | $699219.00 | $1.51M | $294938.00 | $757990.00 |
| Long-term debt | — | — | $35768.00 | $43255.00 | — | — | — | — | — | — |
| Shareholder equity | $119927.00 | $-317062.00 | $-654634.00 | $321538.00 | $-211721.00 | $985165.00 | $16.70M | $6.97M | $4.64M | $3.34M |
| Retained earnings | $-413683.00 | $-1.88M | $-2.35M | $-6.13M | $-6.76M | $-6.30M | $-10.09M | $-14.13M | $-17.85M | $-21.17M |
| Accounts receivable | $10173.00 | — | $1608.00 | $30256.00 | $15468.00 | $11254.00 | $40654.00 | $81752.00 | $60711.00 | $17637.00 |
| Inventory | — | — | — | — | — | $-14351.00 | $-274057.00 | $-135321.00 | $247944.00 | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — |